THERANOSTICS 2016* Amos Hedt
Clarity Pharmaceuticals, NSW, Australia
- This delegate is presenting an abstract at this event.
Presentations this author is a contributor to:
Optimised production of 64Cu-SARTATE for a phase 1 clinical trial (#4)
11:00 AM
Charmaine Jeffery
Refining and Defining NET Targets (submitted abstracts)